Skip to main content
. 2021 Jan 13;9(1):e001787. doi: 10.1136/bmjdrc-2020-001787

Table 3.

Cumulative incidence of major adverse events


Group A (N=3395) Group B (N=1755) P value
n (%) n (%) Group A vs B
Symptomatic hypoglycemia 104 (3.9) 45 (3.2) 0.317
Pancreatitis acute 5 (0.2) 3 (0.9) 0.861
Pancreatitis chronic 2 (0.1) 0 (0.0) 0.310
Skin disorders of non-extrinsic origin 201 (7.9) 90 (6.2) 0.240
Severe infections 71 (2.7) 28 (2.0) 0.222
Cancer 162 (7.4) 62 (4.8) 0.040*

Cumulative incidence (%) of major AEs was calculated per observation period by the Kaplan-Meier method (see figure 2). P values were by log-rank test. Potential factors contributing to cancer development were detailed by Cox regression analysis as shown in online supplemental table 3.

*p value with significance level smaller than 0.05.